Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Trafficking mechanisms and physiological factors mediating a direct gut microbiota-brain neuron interaction

MicrobiotaNeuroTalk

The gut-brain axis has emerged as a complex regulator of system-wide physiology, playing essential roles to maintain homeostasis, including contributions to brain development and activity, affecting host metabolism and behavior. The gut bacterial composition constantly fluctuates, allowing for the regular release of diverse microbe-derived...

Funding Programme
Start Date
End Date
Total Funding
€ 1 875 000
European Countries Involved

Translational Research Network in Motor Disorder Rehabilitation: Advancing understanding of variability in motor control and learning, to enhance clinical practice

TReND

The theoretical understanding of human motor control and learning has a strong impact on the diagnosis and treatment of motor disorders, and vice versa. Recent progress has been made in the understanding of motor control and learning, particularly with respect to understanding the functional role of neuro-behavioural variability that is inherent to...

Funding Programme
Start Date
End Date
Total Funding
€ 2 462 968

TREM2 MICROglia ENGENEering for treating dementiaS (TREM2MICROENGINES)

TREM2MICROENGINES

The project TREM2MICROENGINES aims at demonstrating that raising and restoring TREM2 expression in the brain of Alzheimer’s disease (AD) and Nasu–Hakola disease (NHD) patients, and in particular in their microglia, would result in therapeutic benefit.AD is a severe neurodegenerative disorder that represents the most frequent form of dementia among...

Funding Programme
Start Date
End Date
Total Funding
€ 150 000
European Countries Involved

Tuning the Tracks: Resolving the interplay between microtubule lattice conformation and kinesin-1 selectivity using cryo-EM

TuningTracks

Kinesin-1 transports cellular cargos along microtubules as part of neuronal transport. The localisation of kinesin-1 in neurons is tightly controlled to ensure the coordinated delivery of specific cargoes to the regions where they are required. One mechanism of control is through microtubule regulation, but the details of this are not well...

Funding Programme
Start Date
End Date
Total Funding
€ 187 624
European Countries Involved

Twinning for excellence in biophysics of protein interactions and self-assembly

TWIN2PIPSA

TWIN2PIPSA will improve R&I capacities of FC.ID/ULisboa (Portugal) in the field of protein folding biophysics and conformational diseases by partnering in joint Twinning activities with three world-leading research and technological development performers: the University of Cambridge (UCAM), the University of Copenhagen (UCPH), and Tel Aviv...

Funding Programme
Start Date
End Date
Total Funding
€ 1 228 957
European Countries Involved

Twinning for Excellence in Research, Training and Innovation in Protein Misfolding Diseases

Twin4Promis

Protein misfolding diseases (PMDs) are a large group of human disorders caused by protein misfolding and include serious conditions with high socio-economic impact, such as Alzheimer’s disease, systemic amyloidosis, obesity, cystic fibrosis, retinitis pigmentosa and type 2 diabetes. The vast majority of them remain incurable so there is currently a...

Funding Programme
Start Date
End Date
Total Funding
€ 1 201 375
European Countries Involved

Two-Photon Excited Near-Infrared Emissive Multifunctional Gold Nanoclusters for Imaging and Photothermal Treatment for Alzheimer's Disease

PERSONA

Neurodegenerative diseases are a global epidemic with significant health, social and economic implications and despite intensive research, there is still no cure for them. Alzheimers disease (AD) is the most prevalent neurological disorder having symptoms of the progressive memory loss, neuronal cell death, loss of immune response and cognitive...

Funding Programme
Start Date
End Date
Total Funding
€ 211 754
European Countries Involved

Uncovering molecular and cellular mechanisms of immune cell trafficking across the blood-CSF barrier in autoimmunity

CNS Hidden Door

Immune cells continuously traverse our body, crossing vascular and epithelial barriers; from lymphatic organs into the blood, and from the blood into various tissues for surveillance or to fight infection. However, the brain has long been considered an immune-privileged organ. Barriers protecting the brain against infection or harmful toxic agents...

Funding Programme
Start Date
End Date
Total Funding
€ 2 412 448
European Countries Involved

Understanding the mechanisms of neuronal secretory autophagy

NEURO-SECRET

Neurons transmit information by connecting with other neurons over long distances through their dendrites and axons. Repeated stimulation places a high metabolic demand on these cells, leading to the accumulation of defective organelles and protein aggregates. To maintain protein homeostasis, neurons rely on constitutive autophagy to remove these...

Funding Programme
Start Date
End Date
Total Funding
€ 232 916
European Countries Involved

Understanding the molecular basis of protein folding disorders and protein quality control in muscle

MUSCLE-QC

Mutations in certain proteins can cause their misfolding and aggregation, posing a potential threat to the health of an organism. Protein aggregation is counteracted by protein quality control (PQC) mechanisms that reduce the amounts of damaged molecules. As we age, however, the crucial surveillance mechanisms weaken and become less effective...

Funding Programme
Start Date
End Date
Total Funding
€ 2 498 824
European Countries Involved

Unlocking cognition by Pulsatile GnRH in Alzheimer's DiseasE

UPGRADE

Cognitive decline associated with Alzheimer disease (AD) and other age-related dementias affects ~55 million people worldwide, and is a growing problem in aging European societies. However, most drugs fail at clinical trial, and approved treatments aimed at controlling or reversing pathological changes in the brain do not improve cognition in...

Funding Programme
Start Date
End Date
Total Funding
€ 150 000
European Countries Involved

Unraveling Bilobalide Biosynthesis for Sustainable and Scalable Production in Yeast

Biloba.bio

Ginkgo biloba extracts are among the most widely used plant-based health supplements in the United States and Europe. However, increasing demand has led to unsustainable overharvesting, resulting in Ginkgo biloba being classified as an endangered species. These extracts contain bioactive compounds, such as ginkgolides and bilobalide. Bilobalide, in...

Funding Programme
Start Date
End Date
Total Funding
€ 263 393
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).